NCT06182436Recruiting
Virtual Reality for Pain Management During Dupilumab Injection
Use of Virtual Reality to Improve Pain and Anxiety Management of Children During Dupilumab Injection for Atopic Dermatitis (VR-DERMA)
Source: ClinicalTrials.gov · Last updated 24 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The aim of this within-subject randomized study is to examine the efficacy of a VR immersive game for pain and anxiety management of children during the subcutaneous injection of dupilumab for moderate to severe atopic dermatitis. We will recruit children from 6 to 17 years. The main research question is: 1. Does VR immersive game will generate less anxiety and pain than standard procedures, for children receiving dupilumab injection for moderate to severe atopic dermatitis? 2. Does the occurence of side effects is similar between both study groups? Participants will be randomized according to either sequences: VR-Standard care or Standard care-VR. During the VR sequence, participants will be playing the VR immersive game during the injection. During the Standard care sequence participants will not benefit from any pain management but passive distraction tools will be offered (and documented) to children. The investigators will take measures of pain and anxiety, using validated scales, before and after the procedures at each sequence.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 98 (estimated)
- First submitted
- 17 Aug 2023
- Start date
- 16 May 2024
- Primary completion date
- Jan 2027
- Lead sponsor
- St. Justine's Hospital
- Diseases
- Atopic dermatitis (eczema)
- NCT number
- NCT06182436
What you commit to
- Study type: Interventional
- Planned participants: 98
- From 16 May 2024 to the primary completion date, Jan 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- have a diagnosed cognitive impairment precluding them from playing a virtual reality game,
- suffer from epilepsy considering the nature of the intervention,
Other
- cannot be in a sitting position during the procedure as the virtual reality game requires an angle of at least 30 degrees for head-tracking.
Who the study is looking for
- between the ages of 6 to 17 years old,
- suffering from moderate to severe atopic dermatitis and receiving or about to start subcutaneous injections of dupilumab,
- in the presence of a consenting parent who can understand, read, and write either French or English.
Age in the registry: 6 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CHU Sainte-Justine Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
| St. Justine's Hospital Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.